• No results found

[PDF] Top 20 Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth

Has 10000 "Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth" found on our website. Below are the top 20 most common "Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth".

Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth

Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth

... included. Growth data before HAART initiation also needed to be available to be ...children’s growth be- fore enrollment in the study was retrieved from the hospital medical records and/or the school doctor ... See full document

9

Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)

Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)

... HIV-1 infected patients and was independent of exist- ing normal or reduced vitamin 1,25 (OH)2D levels and reduced albumin values and as a marker for severe nutritional protein deficiency ...is ... See full document

6

The Effect of Protease Inhibitor Therapy on Growth and Body Composition in Human Immunodeficiency Virus Type 1-Infected Children

The Effect of Protease Inhibitor Therapy on Growth and Body Composition in Human Immunodeficiency Virus Type 1-Infected Children

... on growth and body composition were ...borderline effect on height, increasing the z score by 0.17 SD (P ⫽ .10). No effect was found on TSF ...not associated with a change in caloric intake (P ... See full document

8

Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1

Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1

... modeled highly active antiretroviral therapy (HAART) for AIDS in rhesus macaques infected with a chimera (RT-SHIV) of simian immunodeficiency virus containing reverse ... See full document

6

Beneficial Effects of a Combination of Korean Red Ginseng and Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Patients

Beneficial Effects of a Combination of Korean Red Ginseng and Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Patients

... on human immunodeficiency virus type 1 (HIV-1)-infected patients administered highly active antiretroviral therapy (HAART), we analyzed the CD4 ... See full document

5

Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study

Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study

... after highly active antiretroviral therapy (HAART) interruption in chronically human immunodeficiency virus type 1 (HIV-1)-infected patients ... See full document

7

Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia

Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia

... were children under 15 years old. Furthermore, 420,000 Children under 15 years were newly infected with HIV in ...HIV-positive children live in sub-Saharan Africa ...to Children ... See full document

9

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression

... of virus rebound with increasing duration of virus ...lection effect, whereby patients who are most adherent to ther- apy, who experience the least degree of drug toxicity, who achieve the most ... See full document

6

Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy

Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy

... plasma virus receiving HAART. Highly active antiretroviral ...Structured antiretroviral treatment interruptions in chron- ically HIV-1-infected ...related ... See full document

9

Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes

Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes

... This effect could be related to the acquired immunodeficiency (see below) or to a direct interac- tion between the ...transforming growth factor ␤ 1 ...of highly active ... See full document

9

Determining Seminal Plasma Human Immunodeficiency Virus Type 1 Load in the Context of Efficient Highly Active Antiretroviral Therapy

Determining Seminal Plasma Human Immunodeficiency Virus Type 1 Load in the Context of Efficient Highly Active Antiretroviral Therapy

... the human immunodeficiency virus (HIV) ge- nome in semen samples is commonly used to check the safety of semen-processing procedures before medically assisted pro- creation (MAP) and to monitor ... See full document

5

Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: Analysis of Cellular Immune Responses

Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: Analysis of Cellular Immune Responses

... HIV-seronegative children whose age span was similar to that of the children in the present ...range, 1 to 15) and C. albicans (median SI, 3; range, 1 to 45) were somewhat reduced in ... See full document

6

Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south south Nigeria

Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south south Nigeria

... The Human immunodeficiency virus (HIV) pandemic continues to spread in the population making HIV infec- tion one of the most important public health crises in the world ...be infected with ... See full document

9

Determinants of Neurocognitive Impairment in HIV in a Cohort of Patients on Antiretroviral Therapy Followed in Bangui (Central African Republic)

Determinants of Neurocognitive Impairment in HIV in a Cohort of Patients on Antiretroviral Therapy Followed in Bangui (Central African Republic)

... ARV treatment, the virus can persist in the brain causing symptoms of neurological and psychological ...are highly prevalent among PLHIV. Before the era of highly active ... See full document

9

Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis

Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis

... All data were extracted independently by 2 reviewers (X Z and WR X) onto a Microsoft Excel spreadsheet (XP Professional Edition; Microsoft Corp, Redmond, WA), and any discrepancies were resolved by consensus. The ... See full document

32

New and emerging agents in the management of lipodystrophy in HIV-infected patients

New and emerging agents in the management of lipodystrophy in HIV-infected patients

... The best strategy to prevent HIV-associated lipodystrophy is to avoid, if possible, ARV therapies, which are known to be associated with fat modifications. Some NRTIs, especially thymidine analogs, are ... See full document

12

Long-term Experience With Combination Antiretroviral Therapy That Contains Nelfinavir for up to 7 Years in a Pediatric Cohort

Long-term Experience With Combination Antiretroviral Therapy That Contains Nelfinavir for up to 7 Years in a Pediatric Cohort

... 48 children in follow-up, 39 children were included in the study using the NFV-containing treatment ...HIV-1infected children were eligible when they were aged 3 months to 18 ... See full document

11

Persistent Sterile Leukocyturia Is Associated With Impaired Renal Function in Human Immunodeficiency Virus Type 1-Infected Children Treated With Indinavir

Persistent Sterile Leukocyturia Is Associated With Impaired Renal Function in Human Immunodeficiency Virus Type 1-Infected Children Treated With Indinavir

... frequently associated with a mild increase in the urine albumin/creatinine ratio and by microscopic ...those children without persistent sterile leukocyturia. In children younger than ...in ... See full document

9

Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study

Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study

... HIV: human immunodeficiency virus; HAART: highly active antiretroviral therapy; ARV: anti retroviral therapy; KNH: Kenyatta National Hospital; Hb: hemoglobin level; ... See full document

8

Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by Template Analog Reverse Transcriptase Inhibitors Derived by SELEX (Systematic Evolution of Ligands by Exponential Enrichment)

Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by Template Analog Reverse Transcriptase Inhibitors Derived by SELEX (Systematic Evolution of Ligands by Exponential Enrichment)

... precedented level of specificity and avidity of binding. Since they inhibit HIV-1 RT competitively and are unlikely to inhibit other viral or cellular proteins, they should have little to no toxicity (5, 26, 30). ... See full document

13

Show all 10000 documents...